Lithium diisopropylamide structure
|
Common Name | Lithium diisopropylamide | ||
---|---|---|---|---|
CAS Number | 4111-54-0 | Molecular Weight | 107.123 | |
Density | 0.864 g/mL at 25 °C(lit.) | Boiling Point | 65 °C | |
Molecular Formula | C6H14LiN | Melting Point | 38-42ºC | |
MSDS | Chinese USA | Flash Point | 91 °F | |
Symbol |
GHS02, GHS05, GHS07, GHS08, GHS09 |
Signal Word | Danger |
Name | lithium,di(propan-2-yl)azanide |
---|---|
Synonym | More Synonyms |
Density | 0.864 g/mL at 25 °C(lit.) |
---|---|
Boiling Point | 65 °C |
Melting Point | 38-42ºC |
Molecular Formula | C6H14LiN |
Molecular Weight | 107.123 |
Flash Point | 91 °F |
Exact Mass | 107.128632 |
PSA | 3.24000 |
LogP | 1.56950 |
Appearance of Characters | liquid | brown |
Vapour density | >1 (vs air) |
Storage condition | 2-8°C |
Water Solubility | decomposes |
Symbol |
GHS02, GHS05, GHS07, GHS08, GHS09 |
---|---|
Signal Word | Danger |
Hazard Statements | H225-H250-H302-H304-H314-H335-H336-H351-H361f-H373-H411 |
Supplemental HS | May form explosive peroxides. |
Precautionary Statements | P210-P231-P280-P305 + P351 + P338-P370 + P378-P422 |
Hazard Codes | F:Flammable;C:Corrosive;N:Dangerousfortheenvironment; |
Risk Phrases | R11;R14;R15;R19;R35;R51/53;R65;R67 |
Safety Phrases | S26-S36/37/39-S43-S45-S60-S61-S62-S8-S16-S23-S33-S27 |
RIDADR | UN 3399 4.3/PG 2 |
WGK Germany | 3 |
Packaging Group | I |
Hazard Class | 4.2 |
HS Code | 2924199090 |
Precursor 10 | |
---|---|
DownStream 9 | |
HS Code | 2924199090 |
---|---|
Summary | 2924199090. other acyclic amides (including acyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Modulators of hepatic lipoprotein metabolism identified in a search for small-molecule inducers of tribbles pseudokinase 1 expression.
PLoS ONE 10 , e0120295, (2015) Recent genome wide association studies have linked tribbles pseudokinase 1 (TRIB1) to the risk of coronary artery disease (CAD). Based on the observations that increased expression of TRIB1 reduces se... |
|
Clinical relevance of vascular endothelial growth factor type A (VEGFA) and VEGF receptor type 2 (VEGFR2) gene polymorphism in chronic lymphocytic leukemia.
Blood Cells Mol. Dis. 54(2) , 139-43, (2015) Vascular endothelial growth factor type A (VEGFA) is a key regulator of angiogenesis and vascular permeability. Chronic lymphocytic leukemia (CLL) cells are able to secrete VEGFA and express VEGFA rec... |
|
Pendant allyl crosslinking as a tunable shape memory actuator for vascular applications.
Acta Biomater. 24 , 53-63, (2015) Thermo-responsive shape memory polymers (SMPs) can be programmed to fit into small-bore incisions and recover their functional shape upon deployment in the body. This property is of significant intere... |
2-Propanamine, N-(1-methylethyl)-, lithium salt (1:1) |
LDA |
Lithium diisopropylamide |
lithium diisopropylamine |
Lithium diisopropylamide solution |
EINECS 223-893-0 |
UNII-OL028KIW1I |
lithium N,N-diisopropylamide |
Lithium diisopropylamide,LDA |
Lithium diisopropylazanide |
Lithium Diisopropylamide (LDA) |
lithiumdiisopropylamide |
lithium diisopropyl amide |
MFCD00064449 |
lithium di(propan-2-yl)azanide |